| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP hydrolysis activity | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 4.97e-07 | 441 | 159 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 3.29e-05 | 614 | 159 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | unfolded protein binding | 6.79e-05 | 126 | 159 | 7 | GO:0051082 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 GBP5 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 1.54e-04 | 775 | 159 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.40e-04 | 70 | 159 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | heat shock protein binding | 3.35e-04 | 163 | 159 | 7 | GO:0031072 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.67e-04 | 118 | 159 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.70e-04 | 18 | 159 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 GBP5 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 3.88e-04 | 839 | 159 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 GBP5 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 3.94e-04 | 840 | 159 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAD51B ATP5PB KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 DNAH12 GBP5 MACF1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 3.94e-04 | 840 | 159 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 4.47e-04 | 45 | 159 | 4 | GO:0043495 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle | RAD51B TPR KIF23 ATAD5 TRIM21 STAT5A STAT5B BUB1 GPSM2 SGO2 ANAPC5 HSPA2 DYNC1H1 | 1.58e-05 | 407 | 158 | 13 | GO:0045787 |
| GeneOntologyBiologicalProcess | microtubule-based movement | ADCY10 KIF21B KIF23 SPG7 COPG1 LZTFL1 DNAH7 TEKT2 DNAH12 DST CFAP44 HSPA8 DYNC1H1 | 1.13e-04 | 493 | 158 | 13 | GO:0007018 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.14e-04 | 99 | 158 | 6 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.21e-04 | 100 | 158 | 6 | GO:0045103 | |
| GeneOntologyBiologicalProcess | regulation of mitotic sister chromatid separation | 1.31e-04 | 64 | 158 | 5 | GO:0010965 | |
| GeneOntologyBiologicalProcess | positive regulation of cell cycle process | 1.32e-04 | 307 | 158 | 10 | GO:0090068 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid separation | 1.63e-04 | 67 | 158 | 5 | GO:0051306 | |
| GeneOntologyBiologicalProcess | cilium assembly | RPGRIP1L SYNE1 DNAH7 EHD3 CEP350 EVI5 TEKT2 CEP250 RP1 CPLANE1 CFAP44 EVI5L | 1.66e-04 | 444 | 158 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | organelle assembly | TPR KIF23 RPGRIP1L CENPF SYNE1 SPTBN2 RB1CC1 DNAH7 EHD3 CEP350 EVI5 TEKT2 CEP250 AGFG1 GPSM2 WEE2 RP1 CPLANE1 CFAP44 DYNC1H1 EVI5L | 1.66e-04 | 1138 | 158 | 21 | GO:0070925 |
| GeneOntologyBiologicalProcess | tRNA export from nucleus | 1.74e-04 | 3 | 158 | 2 | GO:0006409 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 1.74e-04 | 3 | 158 | 2 | GO:0046544 | |
| GeneOntologyBiologicalProcess | membrane depolarization during bundle of His cell action potential | 1.74e-04 | 3 | 158 | 2 | GO:0086048 | |
| GeneOntologyBiologicalProcess | microtubule-based process | ADCY10 KIF21B TPR KIF23 SPG7 COPG1 LZTFL1 CC2D1A DNAH7 CEP350 TEKT2 DNAH12 DST CEP250 GPSM2 MACF1 RP1 CFAP44 HSPA8 DYNC1H1 | 1.75e-04 | 1058 | 158 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | histone mRNA catabolic process | 1.88e-04 | 15 | 158 | 3 | GO:0071044 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | ADCY10 TPR ILK CENPF SYNE1 SPTBN2 APOA1 PFDN2 TMEM33 ZWINT EHD3 TFRC EVI5 BUB1 XRN1 LRP1 GPSM2 SGO2 WEE2 RP1 ANAPC5 DYNC1H1 EVI5L | 2.34e-04 | 1342 | 158 | 23 | GO:0033043 |
| GeneOntologyCellularComponent | nuclear envelope | TPR TRPC7 CENPF SYNE1 RB1CC1 PHF8 TMEM33 DST AGFG1 SUN3 PRKG2 DYNC1H1 XPOT XPO7 | 9.34e-05 | 560 | 158 | 14 | GO:0005635 |
| GeneOntologyCellularComponent | axon | ADCY10 KIF21B ILK SPG7 HCN1 LMTK2 BCAR1 DDC SLC38A2 DST SYNJ2 SCN5A LRP1 TRPM1 EEA1 HSPA8 DYNC1H1 LGI1 | 1.43e-04 | 891 | 158 | 18 | GO:0030424 |
| GeneOntologyCellularComponent | microtubule | KIF21B KIF23 RPGRIP1L TRIP10 DNAH7 TEKT2 DNAH12 DST SYNJ2 MACF1 RP1 HSPA8 DYNC1H1 | 2.13e-04 | 533 | 158 | 13 | GO:0005874 |
| GeneOntologyCellularComponent | microtubule associated complex | 2.27e-04 | 161 | 158 | 7 | GO:0005875 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ADCY10 TRPC7 CENPF SYNE1 SPTBN2 LMTK2 TRIP10 EHD3 TFRC DST GBP5 SYNJ2 CEP250 SCN5A LRP1 VPS53 HSPA8 TPD52 | 2.54e-04 | 934 | 158 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | cytoplasmic region | RPGRIP1L SPG7 CENPF DNAH7 TEKT2 DNAH12 DST GPSM2 RP1 DYNC1H1 | 4.25e-04 | 360 | 158 | 10 | GO:0099568 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KIF21B KRT3 KIF23 RPGRIP1L TRIP10 DNAH7 PPL TEKT2 KRT76 DNAH12 DST SYNJ2 MACF1 RP1 MYO18B HSPA8 DYNC1H1 | 4.71e-04 | 899 | 158 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | supramolecular fiber | KIF21B KRT3 KIF23 RPGRIP1L ILK SYNE1 TRIP10 DNAH7 PPL TEKT2 KRT76 DNAH12 DST SYNJ2 SCN5A MACF1 RP1 MYO18B HSPA8 DYNC1H1 | 5.93e-04 | 1179 | 158 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KIF21B KRT3 KIF23 RPGRIP1L ILK SYNE1 TRIP10 DNAH7 PPL TEKT2 KRT76 DNAH12 DST SYNJ2 SCN5A MACF1 RP1 MYO18B HSPA8 DYNC1H1 | 6.46e-04 | 1187 | 158 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TBX15 RAD51B TPR RBM44 ORC3 SYNE1 MED14 PSMC5 STAT5A STAT5B COPS7A RTF1 ELL2 CEBPZ SUGP1 AGFG1 SUN3 ANAPC5 HSPA6 HSPA8 XPOT XPO7 | 6.97e-04 | 1377 | 158 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 7.06e-04 | 317 | 158 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | dynein complex | 7.41e-04 | 54 | 158 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | outer kinetochore | 7.63e-04 | 24 | 158 | 3 | GO:0000940 | |
| GeneOntologyCellularComponent | blood microparticle | 8.01e-04 | 144 | 158 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | spindle | TPR KIF23 CENPF MBIP CEP350 EVI5 CEP250 GPSM2 RAB11FIP4 ANAPC5 HSPA2 | 9.34e-04 | 471 | 158 | 11 | GO:0005819 |
| GeneOntologyCellularComponent | prefoldin complex | 1.16e-03 | 7 | 158 | 2 | GO:0016272 | |
| Domain | Spectrin_repeat | 4.63e-06 | 29 | 162 | 5 | IPR002017 | |
| Domain | SPEC | 7.69e-06 | 32 | 162 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 7.69e-06 | 32 | 162 | 5 | IPR018159 | |
| Domain | Plectin | 2.19e-05 | 7 | 162 | 3 | PF00681 | |
| Domain | Plectin_repeat | 2.19e-05 | 7 | 162 | 3 | IPR001101 | |
| Domain | PLEC | 2.19e-05 | 7 | 162 | 3 | SM00250 | |
| Domain | AAA | 3.74e-05 | 144 | 162 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 3.74e-05 | 144 | 162 | 8 | IPR003593 | |
| Domain | Spectrin | 4.25e-05 | 23 | 162 | 4 | PF00435 | |
| Domain | ACTININ_2 | 4.25e-05 | 23 | 162 | 4 | PS00020 | |
| Domain | ACTININ_1 | 4.25e-05 | 23 | 162 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 4.25e-05 | 23 | 162 | 4 | IPR001589 | |
| Domain | HR1_rho-bd | 5.99e-05 | 25 | 162 | 4 | IPR011072 | |
| Domain | - | 1.33e-04 | 12 | 162 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.33e-04 | 12 | 162 | 3 | IPR029047 | |
| Domain | - | 1.72e-04 | 13 | 162 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.72e-04 | 13 | 162 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.72e-04 | 13 | 162 | 3 | IPR029048 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.17e-04 | 14 | 162 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.17e-04 | 14 | 162 | 3 | IPR013602 | |
| Domain | DHC_N2 | 2.17e-04 | 14 | 162 | 3 | PF08393 | |
| Domain | AAA_8 | 2.17e-04 | 14 | 162 | 3 | PF12780 | |
| Domain | DHC_fam | 2.70e-04 | 15 | 162 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 2.70e-04 | 15 | 162 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 2.70e-04 | 15 | 162 | 3 | IPR004273 | |
| Domain | HSP70 | 3.30e-04 | 16 | 162 | 3 | PF00012 | |
| Domain | HSP70_2 | 3.98e-04 | 17 | 162 | 3 | PS00329 | |
| Domain | HSP70_1 | 3.98e-04 | 17 | 162 | 3 | PS00297 | |
| Domain | HSP70_3 | 3.98e-04 | 17 | 162 | 3 | PS01036 | |
| Domain | Prefoldin | 4.04e-04 | 72 | 162 | 5 | IPR009053 | |
| Domain | Hsp_70_fam | 4.75e-04 | 18 | 162 | 3 | IPR013126 | |
| Domain | PFD_beta-like | 1.10e-03 | 6 | 162 | 2 | IPR002777 | |
| Domain | Prefoldin_2 | 1.10e-03 | 6 | 162 | 2 | PF01920 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 3.90.1290.10 | |
| Domain | SURP | 1.10e-03 | 6 | 162 | 2 | PS50128 | |
| Domain | GAR | 1.10e-03 | 6 | 162 | 2 | PS51460 | |
| Domain | GAS2 | 1.10e-03 | 6 | 162 | 2 | PF02187 | |
| Domain | Surp | 1.10e-03 | 6 | 162 | 2 | PF01805 | |
| Domain | SWAP | 1.10e-03 | 6 | 162 | 2 | SM00648 | |
| Domain | - | 1.10e-03 | 6 | 162 | 2 | 3.30.920.20 | |
| Domain | Surp | 1.10e-03 | 6 | 162 | 2 | IPR000061 | |
| Domain | GAS_dom | 1.10e-03 | 6 | 162 | 2 | IPR003108 | |
| Domain | GAS2 | 1.10e-03 | 6 | 162 | 2 | SM00243 | |
| Domain | STAT_TF_DNA-bd_sub | 1.53e-03 | 7 | 162 | 2 | IPR012345 | |
| Domain | STAT | 1.53e-03 | 7 | 162 | 2 | IPR001217 | |
| Domain | STAT_int | 1.53e-03 | 7 | 162 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 1.53e-03 | 7 | 162 | 2 | IPR013801 | |
| Domain | STAT_bind | 1.53e-03 | 7 | 162 | 2 | PF02864 | |
| Domain | STAT_int | 1.53e-03 | 7 | 162 | 2 | PF02865 | |
| Domain | - | 1.53e-03 | 7 | 162 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 1.53e-03 | 7 | 162 | 2 | PF01017 | |
| Domain | - | 1.53e-03 | 7 | 162 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 1.53e-03 | 7 | 162 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 1.53e-03 | 7 | 162 | 2 | IPR015988 | |
| Domain | - | 1.53e-03 | 7 | 162 | 2 | 2.60.40.630 | |
| Domain | Ubox | 2.02e-03 | 8 | 162 | 2 | SM00504 | |
| Domain | STAT_TF_alpha | 2.02e-03 | 8 | 162 | 2 | IPR013800 | |
| Domain | PPR | 2.02e-03 | 8 | 162 | 2 | PS51375 | |
| Domain | CH | 2.45e-03 | 65 | 162 | 4 | SM00033 | |
| Domain | - | 2.59e-03 | 9 | 162 | 2 | 1.10.287.370 | |
| Domain | CNMP_BINDING_1 | 2.64e-03 | 32 | 162 | 3 | PS00888 | |
| Domain | CNMP_BINDING_2 | 2.64e-03 | 32 | 162 | 3 | PS00889 | |
| Domain | P-loop_NTPase | RAD51B ADCY10 KIF21B KIF23 SPG7 ABCA13 ATAD5 PSMC5 CHD7 DNAH7 EHD3 NLRP9 DNAH12 GBP5 MYO18B DYNC1H1 | 2.91e-03 | 848 | 162 | 16 | IPR027417 |
| Domain | cNMP | 3.15e-03 | 34 | 162 | 3 | SM00100 | |
| Domain | cNMP_binding | 3.15e-03 | 34 | 162 | 3 | PF00027 | |
| Domain | Ion_trans_dom | 3.17e-03 | 114 | 162 | 5 | IPR005821 | |
| Domain | Ion_trans | 3.17e-03 | 114 | 162 | 5 | PF00520 | |
| Domain | CH | 3.21e-03 | 70 | 162 | 4 | PF00307 | |
| Domain | Ubox_domain | 3.21e-03 | 10 | 162 | 2 | IPR003613 | |
| Domain | - | 3.37e-03 | 71 | 162 | 4 | 1.10.418.10 | |
| Domain | cNMP-bd_dom | 3.42e-03 | 35 | 162 | 3 | IPR000595 | |
| Domain | CNMP_BINDING_3 | 3.42e-03 | 35 | 162 | 3 | PS50042 | |
| Domain | CH | 3.73e-03 | 73 | 162 | 4 | PS50021 | |
| Domain | CH-domain | 4.11e-03 | 75 | 162 | 4 | IPR001715 | |
| Domain | cNMP-bd-like | 4.33e-03 | 38 | 162 | 3 | IPR018490 | |
| Domain | GrpE_coiled_coil | 4.66e-03 | 12 | 162 | 2 | IPR013805 | |
| Domain | Dynein_HC_stalk | 6.35e-03 | 14 | 162 | 2 | IPR024743 | |
| Domain | ATPase_dyneun-rel_AAA | 6.35e-03 | 14 | 162 | 2 | IPR011704 | |
| Domain | K_chnl_volt-dep_EAG/ELK/ERG | 6.35e-03 | 14 | 162 | 2 | IPR003938 | |
| Domain | MT | 6.35e-03 | 14 | 162 | 2 | PF12777 | |
| Domain | AAA_5 | 6.35e-03 | 14 | 162 | 2 | PF07728 | |
| Domain | IBN_N | 7.29e-03 | 15 | 162 | 2 | PF03810 | |
| Domain | - | 7.84e-03 | 261 | 162 | 7 | 1.10.238.10 | |
| Domain | cNMP-bd_CS | 8.28e-03 | 16 | 162 | 2 | IPR018488 | |
| Domain | IBN_N | 8.28e-03 | 16 | 162 | 2 | SM00913 | |
| Domain | PINT | 8.28e-03 | 16 | 162 | 2 | SM00088 | |
| Domain | - | 8.33e-03 | 48 | 162 | 3 | 2.60.120.10 | |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF21B DENND4A KIF23 COPG1 SPTBN2 APOA1 TRIP10 COPS7A TFRC GJB1 SYNJ2 AGFG1 LRP1 ANKRD28 VPS53 HSPA8 DYNC1H1 TPD52 | 1.49e-05 | 645 | 125 | 18 | MM15232 |
| Pathway | REACTOME_VESICLE_MEDIATED_TRANSPORT | KIF21B DENND4A KIF23 COPG1 SPTBN2 APOA1 RALGAPA2 TRIP10 COPS7A TFRC GJB1 SYNJ2 AGFG1 LRP1 ANKRD28 VPS53 HSPA8 DYNC1H1 TPD52 | 2.03e-05 | 725 | 125 | 19 | M27507 |
| Pathway | REACTOME_MEMBRANE_TRAFFICKING | KIF21B DENND4A KIF23 COPG1 SPTBN2 RALGAPA2 TRIP10 COPS7A TFRC GJB1 SYNJ2 AGFG1 ANKRD28 VPS53 HSPA8 DYNC1H1 TPD52 | 4.03e-05 | 630 | 125 | 17 | M11480 |
| Pubmed | TPP2 TPR KIF23 COPG1 CENPF TUT7 SPTBN2 PSMC5 CHD7 SSB IGF2BP3 DST SUGP2 CEBPZ GLYR1 XRN1 ANKRD28 MACF1 HSPA2 DYNC1H1 XPOT XPO7 | 7.53e-13 | 653 | 165 | 22 | 22586326 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | TPR CACNA2D1 KIF23 COPG1 CENPF ORC3 SYNE1 APOA1 PFDN2 SSB PPL ZWINT COPS7A TFRC CEP350 ZNF8 IGF2BP3 SYNJ2 ZNF451 BUB1 SGO2 EEA1 ANAPC5 DYNC1H1 DCAF12 | 2.56e-10 | 1155 | 165 | 25 | 20360068 |
| Pubmed | KIF21B SYNE1 TRIM21 DST DNAJC10 CEBPZ SCN5A CFAP44 HSPA2 HSPA6 HSPA8 | 1.73e-09 | 187 | 165 | 11 | 26460568 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR KIF23 ILK COPG1 TUT7 PSMC5 PSMD3 CHD7 PHF8 USP16 TMEM33 TFRC BLVRA DST SUGP2 CEBPZ GLYR1 XRN1 PPP1R37 ANKRD28 MACF1 HSPA6 HSPA8 DYNC1H1 XPOT | 6.32e-09 | 1353 | 165 | 25 | 29467282 |
| Pubmed | KIF21B TPP2 TPR CACNA2D1 KIF23 CENPF HCN1 SYNE1 SPTBN2 TRIM21 CHD7 EHD3 DST FARP1 LRP1 ANKRD28 MACF1 UNC79 HSPA8 DYNC1H1 LGI1 | 6.95e-09 | 963 | 165 | 21 | 28671696 | |
| Pubmed | COPG1 TUT7 PSMC5 PSMD3 PFDN2 SSB USP16 TMEM33 COPS7A CEP350 DST SUGP2 SYNJ2 HSPA6 HSPA8 XPOT | 8.91e-09 | 547 | 165 | 16 | 37267103 | |
| Pubmed | ATP5PB KIF23 ATAD5 KCMF1 PSMC5 PSMD3 CC2D1A CHD7 SSB PHF8 MBIP STAT5A STAT5B TFRC TRIM33 IGF2BP3 DST SUGP2 GLYR1 ZNF451 XRN1 SUGP1 ANKRD28 DYNC1H1 XPOT | 1.85e-08 | 1429 | 165 | 25 | 35140242 | |
| Pubmed | ATP5PB TPP2 CACNA2D1 KIF23 COPG1 SPTBN2 PSMC5 LAMC1 PSMD3 SSB TMEM33 TFRC BLVRA EVI5 IGF2BP3 DST DNAJC10 CEBPZ ANKRD28 HSPA2 VPS53 HSPA6 DYNC1H1 EVI5L XPOT | 2.15e-08 | 1440 | 165 | 25 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TPP2 ILK COPG1 KCMF1 LZTFL1 PSMC5 PSMD3 PFDN2 SSB BCAR1 TRIP10 RSU1 STAT5B COPS7A RTF1 IGF2BP3 AGFG1 ANKRD28 MACF1 HSPA6 HSPA8 DYNC1H1 TPD52 XPOT XPO7 | 2.63e-08 | 1455 | 165 | 25 | 22863883 |
| Pubmed | TPP2 RPGRIP1L ATAD5 SPTBN2 LMTK2 PSMC5 PSMD3 PFDN2 BCAR1 RB1CC1 PHF8 CEP350 CEBPZ FARP1 GLYR1 PPP1R37 ANKRD28 HSPA2 HSPA6 TPD52 XPOT | 3.02e-08 | 1049 | 165 | 21 | 27880917 | |
| Pubmed | ATP5PB KIF23 ILK COPG1 PSMC5 TRIM21 RSU1 RUFY2 IGF2BP3 SUGP2 GLYR1 MACF1 EEA1 HSPA8 DYNC1H1 XPOT | 3.29e-08 | 601 | 165 | 16 | 33658012 | |
| Pubmed | ATP5PB ATAD5 SYNE1 SPTBN2 LAMC1 CC2D1A RB1CC1 USP16 RSU1 SNX29 TMEM33 TFRC SLC38A2 C5orf34 DNAJC10 CEBPZ FARP1 GLYR1 ZNF451 ANKRD28 MACF1 HSPA2 HSPA6 HSPA8 TPD52 | 4.00e-08 | 1487 | 165 | 25 | 33957083 | |
| Pubmed | TPP2 TPR COPG1 CENPF KCMF1 PSMD3 TRIM21 CHD7 RB1CC1 TRIM33 SUGP1 TRPM1 HSPA8 | 6.20e-08 | 396 | 165 | 13 | 26687479 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | COPG1 ATAD5 CC2D1A PFDN2 USP16 RSU1 TMEM33 CEP350 BLVRA IGF2BP3 SUGP2 SYNJ2 CEBPZ FARP1 XRN1 AGFG1 MACF1 | 7.33e-08 | 724 | 165 | 17 | 36232890 |
| Pubmed | KIF23 RPGRIP1L CHAF1A TUT7 PSMC5 CHD7 ZWINT TFRC CEP350 SLC38A2 SYNJ2 CEBPZ ZNF451 XRN1 SUGP1 AGFG1 ANKRD28 | 8.74e-08 | 733 | 165 | 17 | 34672954 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | RPGRIP1L MED14 PSMC5 PSMD3 TRIM21 PFDN2 RALGAPA2 TFRC KRT76 EEA1 CPLANE1 HSPA2 HSPA6 HSPA8 XPOT | 9.14e-08 | 564 | 165 | 15 | 21565611 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP5PB TPR CACNA2D1 CENPF SYNE1 SPTBN2 PSMC5 LAMC1 PSMD3 RB1CC1 TFRC CEP350 IGF2BP3 DST SUGP2 CEBPZ MACF1 EEA1 DYNC1H1 XPO7 | 9.83e-08 | 1024 | 165 | 20 | 24711643 |
| Pubmed | 1.05e-07 | 3 | 165 | 3 | 18552213 | ||
| Pubmed | TPR CENPF LAMC1 CHD7 RB1CC1 MBIP ZNF8 DST BUB1 XRN1 LRP1 ANKRD28 HSPA6 | 1.16e-07 | 418 | 165 | 13 | 34709266 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR COPG1 SPTBN2 LZTFL1 PSMC5 PSMD3 TRIM21 PFDN2 SSB TFRC IGF2BP3 DST PDRG1 AGFG1 MACF1 EEA1 HSPA2 HSPA6 HSPA8 DYNC1H1 TPD52 | 1.39e-07 | 1149 | 165 | 21 | 35446349 |
| Pubmed | KIF23 RPGRIP1L COPG1 CC2D1A DNAH7 PPL CEP350 SLC38A2 TRIM33 IGF2BP3 DST SUGP2 XRN1 ANKRD28 FLRT2 DYNC1H1 XPO7 | 1.99e-07 | 777 | 165 | 17 | 35844135 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ATP5PB TPP2 TPR ILK COPG1 PSMD3 CC2D1A PFDN2 SSB TRIP10 RSU1 TMEM33 TFRC RTF1 IGF2BP3 DNAJC10 PDRG1 CEBPZ MACF1 HSPA6 HSPA8 DYNC1H1 XPOT | 2.69e-07 | 1415 | 165 | 23 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | ATP5PB TPR TRAF1 DENND4A KIF23 COPG1 CENPF SYNE1 CHAF1A PSMC5 PSMD3 SSB TMEM33 TFRC SLC38A2 CEBPZ GLYR1 SGO2 EEA1 MYO18B HSPA8 DYNC1H1 XPOT | 3.04e-07 | 1425 | 165 | 23 | 30948266 |
| Pubmed | UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. | 3.38e-07 | 13 | 165 | 4 | 27477512 | |
| Pubmed | TPR KIF23 SPTBN2 MED14 CC2D1A PHF8 MBIP TMEM33 SUGP2 CEBPZ XRN1 HSPA6 DYNC1H1 TPD52 | 4.14e-07 | 549 | 165 | 14 | 38280479 | |
| Pubmed | ATP5PB KIF23 ATAD5 CHAF1A KCMF1 MED14 MBIP CEP350 ZNF8 IGF2BP3 DST GLYR1 XRN1 SGO2 TPD52 | 5.04e-07 | 645 | 165 | 15 | 25281560 | |
| Pubmed | COPG1 TUT7 SPTBN2 LAMC1 CC2D1A APOA1 PFDN2 CHD7 SSB RSU1 TMEM33 CEP350 IGF2BP3 SUGP2 CEBPZ FARP1 GLYR1 ZNF451 TRPM1 EEA1 FBXO21 DYNC1H1 | 6.21e-07 | 1371 | 165 | 22 | 36244648 | |
| Pubmed | ATP5PB KRT3 PSMC5 PSMD3 TRIM21 PFDN2 CHD7 SSB PHF8 DNAH7 IGF2BP3 KRT76 DNAJC10 GLYR1 MACF1 FBXO21 HSPA2 HSPA6 HSPA8 DYNC1H1 | 6.39e-07 | 1153 | 165 | 20 | 29845934 | |
| Pubmed | TPR SYNE1 CHAF1A SPTBN2 TRIM21 CEP350 DST SYNJ2 ZNF451 CEP250 AGFG1 MACF1 CPLANE1 | 6.39e-07 | 486 | 165 | 13 | 20936779 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | ATP5PB KIF21B TPP2 TPR SPTBN2 PSMC5 LAMC1 PSMD3 PFDN2 IGF2BP3 CEP250 MACF1 EEA1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 6.58e-07 | 847 | 165 | 17 | 35235311 |
| Pubmed | 6.61e-07 | 267 | 165 | 10 | 33417871 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | ATP5PB TPR SYNE1 LMTK2 PSMC5 PSMD3 PFDN2 TFRC CEP350 PDRG1 PPP1R37 ANKRD28 DYNC1H1 XPOT | 6.88e-07 | 573 | 165 | 14 | 28330616 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RPGRIP1L TUT7 SPTBN2 CC2D1A PFDN2 PHF8 RSU1 DNAH7 CEP350 SYNJ2 FARP1 CEP250 XRN1 ANKRD28 CPLANE1 HSPA2 DYNC1H1 | 7.25e-07 | 853 | 165 | 17 | 28718761 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 7.36e-07 | 208 | 165 | 9 | 33230847 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF23 CENPF ATAD5 TUT7 MED14 PSMD3 SSB PHF8 IGF2BP3 DNAJC10 SUGP2 CEBPZ GLYR1 XRN1 MACF1 SGO2 | 7.56e-07 | 759 | 165 | 16 | 35915203 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B CENPF SPTBN2 KCMF1 STAT5A COPS7A RTF1 SNX14 DNAH12 DNAJC10 ANKRD28 RP1 XPOT | 8.21e-07 | 497 | 165 | 13 | 36774506 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | TPP2 TPR ILK CENPF SPTBN2 PSMD3 SSB IGF2BP3 DST SUGP2 FARP1 XRN1 MACF1 | 8.39e-07 | 498 | 165 | 13 | 36634849 |
| Pubmed | DENND4A RB1CC1 SNX29 TFRC DST DNAJC10 AGFG1 PPP1R37 VPS53 TPD52 | 1.19e-06 | 285 | 165 | 10 | 34369648 | |
| Pubmed | RAD51B ATP5PB KRT3 DENND4A CENPF SYNE1 CHAF1A SPTBN2 PSMD3 PPARA PPL TFRC KRT76 DST DNAJC10 CEBPZ XRN1 MACF1 EEA1 HSPA2 HSPA6 HSPA8 | 1.43e-06 | 1442 | 165 | 22 | 35575683 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | ATP5PB KIF21B HCN1 PSMC5 PSMD3 SSB BCAR1 EHD3 TEKT2 DST HSPA2 HSPA8 DYNC1H1 LGI1 | 1.77e-06 | 621 | 165 | 14 | 22794259 |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 1.81e-06 | 120 | 165 | 7 | 31413325 | |
| Pubmed | ATP5PB COPG1 PSMC5 PSMD3 SSB TFRC TRIM33 DNAJC10 SUGP2 HSPA2 HSPA6 HSPA8 DYNC1H1 XPOT | 2.41e-06 | 638 | 165 | 14 | 33239621 | |
| Pubmed | CYLD Regulates Centriolar Satellites Proteostasis by Counteracting the E3 Ligase MIB1. | 2.75e-06 | 182 | 165 | 8 | 31067453 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | SPTBN2 PSMD3 SSB IGF2BP3 DST SUGP2 CEBPZ SCN5A HSPA2 HSPA6 HSPA8 DYNC1H1 | 3.28e-06 | 477 | 165 | 12 | 31300519 |
| Pubmed | TPP2 CACNA2D1 KIF23 COPG1 PSMC5 LAMC1 RB1CC1 TMEM33 TFRC BLVRA SLC38A2 IGF2BP3 DST DNAJC10 MACF1 EEA1 HSPA6 HSPA8 DYNC1H1 XPOT | 3.82e-06 | 1297 | 165 | 20 | 33545068 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP5PB TPP2 TPR ILK COPG1 PSMC5 PSMD3 TMEM33 TFRC SYNJ2 SUGP1 HSPA2 HSPA8 DYNC1H1 | 3.89e-06 | 665 | 165 | 14 | 30457570 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TPR ILK COPG1 ORC3 PSMC5 PSMD3 TRIM21 CHD7 BUB1 MACF1 HSPA6 HSPA8 DYNC1H1 | 4.63e-06 | 582 | 165 | 13 | 20467437 |
| Pubmed | TPP2 TPR KIF23 COPG1 CENPF PSMC5 PSMD3 SSB TFRC IGF2BP3 DNAJC10 HSPA8 | 4.69e-06 | 494 | 165 | 12 | 26831064 | |
| Pubmed | DENND4A ILK SYNE1 LAMC1 PPARA RSU1 DST ANKRD28 MACF1 MYO18B HSPA8 PLCE1 | 4.98e-06 | 497 | 165 | 12 | 23414517 | |
| Pubmed | 5.72e-06 | 25 | 165 | 4 | 27483141 | ||
| Pubmed | 5.77e-06 | 8 | 165 | 3 | 30591555 | ||
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | ATP5PB KIF21B RPGRIP1L COPG1 ORC3 TRIM21 CHD7 STARD6 RTF1 RUFY2 EVI5 SLC38A2 KRT76 ELL2 GBP5 SYNJ2 CEP250 SGO2 VPS53 | 7.60e-06 | 1242 | 165 | 19 | 30973865 |
| Pubmed | 7.88e-06 | 210 | 165 | 8 | 16565220 | ||
| Pubmed | 8.63e-06 | 9 | 165 | 3 | 21763498 | ||
| Pubmed | 8.86e-06 | 282 | 165 | 9 | 23667531 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | KIF23 ORC3 TUT7 MED14 LMTK2 SSB TRIP10 DNAJC10 CEBPZ SGO2 ANAPC5 | 9.02e-06 | 440 | 165 | 11 | 34244565 |
| Pubmed | 9.41e-06 | 360 | 165 | 10 | 33111431 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR KIF23 ATAD5 PSMC5 CC2D1A USP16 SNX29 IGF2BP3 DST SUGP2 XRN1 SUGP1 AGFG1 ANKRD28 MACF1 HSPA8 | 1.05e-05 | 934 | 165 | 16 | 33916271 |
| Pubmed | 1.09e-05 | 61 | 165 | 5 | 19875381 | ||
| Pubmed | RAD51B TPP2 TPR ILK SPTBN2 APOA1 COPS7A DST LRP1 ANKRD28 MACF1 HSPA2 XPO7 | 1.15e-05 | 634 | 165 | 13 | 34591612 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ATP5PB DENND4A KIF23 ILK COPG1 CHAF1A PSMC5 PSMD3 PFDN2 SSB RB1CC1 RSU1 TMEM33 RTF1 IGF2BP3 SGO2 UNC79 DYNC1H1 XPO7 | 1.21e-05 | 1284 | 165 | 19 | 17353931 |
| Pubmed | HCN1 SYNE1 SPTBN2 PFDN2 USP16 STAT5B RUFY2 CEP350 TRIM33 DST ZNF451 LRP1 GPSM2 MACF1 RAB11FIP4 HSPA2 DYNC1H1 LGI1 XPOT | 1.22e-05 | 1285 | 165 | 19 | 35914814 | |
| Pubmed | Stat5 regulates cellular iron uptake of erythroid cells via IRP-2 and TfR-1. | 1.23e-05 | 10 | 165 | 3 | 18694996 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.23e-05 | 10 | 165 | 3 | 11932435 | |
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 12832005 | ||
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 7906708 | ||
| Pubmed | 1.23e-05 | 10 | 165 | 3 | 23921388 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR KIF23 COPG1 SYNE1 SPTBN2 TRIM21 BCAR1 RB1CC1 IGF2BP3 DST CEBPZ GLYR1 HSPA2 HSPA6 HSPA8 DYNC1H1 | 1.28e-05 | 949 | 165 | 16 | 36574265 |
| Pubmed | DENND4A ORC3 TUT7 TMEM33 STAT5B DST DNAJC10 BUB1 XRN1 ANKRD28 CMTR2 ANAPC5 PLCE1 | 1.50e-05 | 650 | 165 | 13 | 38777146 | |
| Pubmed | ARMC5 is part of an RPB1-specific ubiquitin ligase implicated in adrenal hyperplasia. | 1.53e-05 | 166 | 165 | 7 | 35687106 | |
| Pubmed | RPGRIP1L CHAF1A TRIM21 CHD7 RB1CC1 USP16 RSU1 TRIM33 CEBPZ ANKRD28 UNC79 | 1.63e-05 | 469 | 165 | 11 | 27634302 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DENND4A KIF23 ILK LMTK2 LAMC1 CC2D1A BCAR1 DNAH7 CEP350 SLC38A2 DST SYNJ2 XRN1 AGFG1 MACF1 | 1.66e-05 | 861 | 165 | 15 | 36931259 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SYNE1 SPTBN2 MED14 CHD7 TMEM33 ZNF8 IGF2BP3 DST DNAJC10 SUGP2 FARP1 GLYR1 SUGP1 MACF1 HSPA6 HSPA8 DYNC1H1 | 1.68e-05 | 1082 | 165 | 17 | 38697112 |
| Pubmed | 1.72e-05 | 67 | 165 | 5 | 29735542 | ||
| Pubmed | TPR SPG7 TUT7 LMTK2 DEPDC1 CHD7 EHD3 COPS7A SLC38A2 C5orf34 FARP1 GLYR1 RXFP2 MACF1 CPLANE1 XPOT ZNF445 | 1.72e-05 | 1084 | 165 | 17 | 11544199 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ATP5PB COPG1 PSMC5 LAMC1 PSMD3 CC2D1A APOA1 PPL TFRC DNAJC10 XRN1 LRP1 TXNDC16 ANKRD28 FBXO21 XPOT | 1.76e-05 | 974 | 165 | 16 | 28675297 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.78e-05 | 235 | 165 | 8 | 30258100 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | SPTBN2 CC2D1A RB1CC1 PPL DST SYNJ2 XRN1 AGFG1 PPP1R37 MACF1 HSPA8 TPD52 | 1.79e-05 | 565 | 165 | 12 | 25468996 |
| Pubmed | 1.89e-05 | 237 | 165 | 8 | 29564676 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 2.03e-05 | 313 | 165 | 9 | 38270169 | |
| Pubmed | ATP5PB TPP2 COPG1 LZTFL1 PSMC5 PSMD3 SSB TMEM33 TFRC AGFG1 ANAPC5 HSPA6 HSPA8 DYNC1H1 XPOT | 2.08e-05 | 878 | 165 | 15 | 37223481 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | KIF23 CENPF ORC3 CHAF1A PSMC5 PSMD3 TMEM33 TFRC RTF1 TRIM33 SUGP2 CEBPZ GLYR1 SUGP1 HSPA6 HSPA8 | 2.12e-05 | 989 | 165 | 16 | 36424410 |
| Pubmed | HIV-1 viral protein R (Vpr) and its interactions with host cell. | 2.24e-05 | 12 | 165 | 3 | 19275587 | |
| Pubmed | 2.24e-05 | 12 | 165 | 3 | 16497536 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 23151802 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 26999798 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 22196377 | ||
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 2.24e-05 | 2 | 165 | 2 | 31443474 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 2.24e-05 | 2 | 165 | 2 | 21127177 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 16289657 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25552366 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25470773 | ||
| Pubmed | LRP1 and APOA1 Polymorphisms: Impact on Warfarin International Normalized Ratio-Related Phenotypes. | 2.24e-05 | 2 | 165 | 2 | 32282500 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 11002341 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 2.24e-05 | 2 | 165 | 2 | 21431790 | |
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 28500076 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 21826656 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 7720707 | ||
| Pubmed | 2.24e-05 | 2 | 165 | 2 | 25845745 | ||
| Interaction | SIRT7 interactions | TPP2 TPR KIF23 COPG1 CENPF TUT7 SPTBN2 PSMC5 CHD7 SSB IGF2BP3 DST SUGP2 CEBPZ GLYR1 XRN1 ANKRD28 MACF1 HSPA2 DYNC1H1 XPOT XPO7 | 1.72e-07 | 744 | 164 | 22 | int:SIRT7 |
| Interaction | APC interactions | TPR TRAF1 KIF23 RPGRIP1L SYNE1 SPTBN2 TRIM21 RB1CC1 DST CEP250 BUB1 AGFG1 ANKRD28 MACF1 RP1 | 7.13e-07 | 389 | 164 | 15 | int:APC |
| Interaction | PHF21A interactions | TPR TRAF1 CENPF CHD7 RB1CC1 MBIP ZNF8 DST BUB1 XRN1 ANKRD28 VPS53 HSPA6 | 4.88e-06 | 343 | 164 | 13 | int:PHF21A |
| Interaction | RAB4A interactions | DENND4A SYNE1 LMTK2 CC2D1A SNX29 TFRC RUFY2 SLC38A2 DST AGFG1 LRP1 PPP1R37 EEA1 VPS53 TPD52 | 5.17e-06 | 457 | 164 | 15 | int:RAB4A |
| Interaction | CIT interactions | TPR KIF23 ILK CENPF ORC3 HCN1 SYNE1 CHAF1A SPTBN2 PSMC5 SSB RALGAPA2 TMEM33 TFRC C5orf34 IGF2BP3 NLRP9 DNAH12 DNAJC10 SUGP2 CEBPZ GLYR1 MACF1 FBXO21 HSPA2 HSPA6 HSPA8 DYNC1H1 XPOT | 5.64e-06 | 1450 | 164 | 29 | int:CIT |
| Interaction | CCDC8 interactions | ATP5PB TPR CACNA2D1 SPTBN2 LAMC1 PSMD3 RB1CC1 CEP350 IGF2BP3 DNAH12 DST SUGP2 GLYR1 CEP250 MACF1 EEA1 DYNC1H1 XPO7 | 6.96e-06 | 656 | 164 | 18 | int:CCDC8 |
| Interaction | GAN interactions | KIF21B SYNE1 TRIM21 DST DNAJC10 CEBPZ SCN5A CFAP44 HSPA2 HSPA6 HSPA8 | 7.44e-06 | 253 | 164 | 11 | int:GAN |
| Interaction | WEE2-AS1 interactions | 7.71e-06 | 163 | 164 | 9 | int:WEE2-AS1 | |
| Interaction | KDM1A interactions | ATP5PB TPR RPGRIP1L CENPF CHAF1A LAMC1 TRIM21 CHD7 RB1CC1 PHF8 CEP350 ZNF8 DST GLYR1 ZNF451 BUB1 MYLIP XRN1 LRP1 ANKRD28 VPS53 HSPA6 | 8.21e-06 | 941 | 164 | 22 | int:KDM1A |
| Interaction | CEP170 interactions | KIF23 RPGRIP1L CC2D1A BCAR1 RB1CC1 RUFY2 TEKT2 FARP1 CEP250 AGFG1 VPS53 HSPA8 | 1.19e-05 | 318 | 164 | 12 | int:CEP170 |
| Interaction | PTGES3 interactions | KIF23 ILK COPG1 CHAF1A MED14 CC2D1A PFDN2 DEPDC1 CHD7 ARMCX5 C5orf34 PDRG1 ZNF451 TPD52 | 1.42e-05 | 437 | 164 | 14 | int:PTGES3 |
| Interaction | HDLBP interactions | MGAT4D COPG1 TUT7 KCMF1 TRIM21 CHD7 USP16 TMEM33 STAT5B TRIM33 SUGP2 FARP1 GLYR1 ZNF451 ANKRD28 TRPM1 HSPA2 HSPA8 DYNC1H1 XPOT | 2.17e-05 | 855 | 164 | 20 | int:HDLBP |
| Interaction | FBXL6 interactions | COPG1 TUT7 PSMC5 PSMD3 PFDN2 SSB USP16 TMEM33 COPS7A CEP350 DST SUGP2 SYNJ2 HSPA6 HSPA8 XPOT | 2.31e-05 | 583 | 164 | 16 | int:FBXL6 |
| Interaction | FBXO22 interactions | KIF21B CENPF SPTBN2 KCMF1 TRIM21 BCAR1 STAT5A COPS7A RTF1 SNX14 DNAH12 DNAJC10 ANKRD28 RP1 XPOT | 3.67e-05 | 540 | 164 | 15 | int:FBXO22 |
| Interaction | MAD2L1 interactions | 4.25e-05 | 252 | 164 | 10 | int:MAD2L1 | |
| Interaction | NR1I3 interactions | 4.33e-05 | 48 | 164 | 5 | int:NR1I3 | |
| Interaction | KBTBD4 interactions | TPP2 TPR PSMD3 CC2D1A SUGP2 PDRG1 XRN1 SUGP1 AGFG1 HSPA6 HSPA8 | 5.79e-05 | 316 | 164 | 11 | int:KBTBD4 |
| Interaction | CENPA interactions | KIF23 ATAD5 ORC3 CHAF1A CHD7 PHF8 RTF1 CEBPZ GLYR1 ZNF451 SGO2 HSPA8 | 6.30e-05 | 377 | 164 | 12 | int:CENPA |
| Interaction | PPP1R12A interactions | TPP2 TPR KIF23 RPGRIP1L ILK CHAF1A TRIM21 RB1CC1 MACF1 HSPA2 HSPA8 | 6.85e-05 | 322 | 164 | 11 | int:PPP1R12A |
| Interaction | IFITM3 interactions | ATP5PB KIF23 SPTBN2 KCMF1 PSMC5 CC2D1A BCAR1 RALGAPA2 SNX29 TMEM33 TFRC SNX14 AGFG1 EEA1 | 8.11e-05 | 513 | 164 | 14 | int:IFITM3 |
| Interaction | INSIG1 interactions | 8.20e-05 | 127 | 164 | 7 | int:INSIG1 | |
| Interaction | MIS12 interactions | 8.82e-05 | 89 | 164 | 6 | int:MIS12 | |
| Interaction | RPGRIP1L interactions | KIF23 RPGRIP1L PSMC5 PSMD3 TFRC CEP350 ANKRD28 CPLANE1 DYNC1H1 | 9.73e-05 | 225 | 164 | 9 | int:RPGRIP1L |
| Interaction | APEX1 interactions | KIF23 ILK CENPF ATAD5 ORC3 CHAF1A SPTBN2 LZTFL1 PSMC5 CC2D1A CHD7 BCAR1 PHF8 MBIP ZWINT RTF1 SNX14 DNAJC10 CEBPZ GLYR1 FBXO21 ANAPC5 HSPA8 XPOT | 9.89e-05 | 1271 | 164 | 24 | int:APEX1 |
| Interaction | CPLANE2 interactions | 1.10e-04 | 12 | 164 | 3 | int:CPLANE2 | |
| Interaction | GNB1L interactions | 1.18e-04 | 59 | 164 | 5 | int:GNB1L | |
| Interaction | PNPLA5 interactions | 1.44e-04 | 33 | 164 | 4 | int:PNPLA5 | |
| Interaction | LIMS1 interactions | 1.50e-04 | 98 | 164 | 6 | int:LIMS1 | |
| Interaction | MYCBP2 interactions | KIF21B TPR SPTBN2 FAXC TRIM21 DST MYLIP MACF1 EEA1 UNC79 DYNC1H1 | 1.62e-04 | 355 | 164 | 11 | int:MYCBP2 |
| Interaction | KRT37 interactions | 1.68e-04 | 100 | 164 | 6 | int:KRT37 | |
| Interaction | EXOC1 interactions | 1.72e-04 | 143 | 164 | 7 | int:EXOC1 | |
| Interaction | RHOV interactions | 1.74e-04 | 243 | 164 | 9 | int:RHOV | |
| Interaction | VILL interactions | 1.80e-04 | 14 | 164 | 3 | int:VILL | |
| Interaction | BRCA1 interactions | RAD51B TPP2 TPR KIF23 ILK COPG1 CENPF ORC3 CHAF1A PSMC5 PSMD3 SSB STAT5A TFRC CEP350 TRIM33 IGF2BP3 DST DNAJC10 ANKRD28 SGO2 HSPA8 DYNC1H1 | 2.02e-04 | 1249 | 164 | 23 | int:BRCA1 |
| Interaction | FAM83F interactions | 2.03e-04 | 36 | 164 | 4 | int:FAM83F | |
| Interaction | SQSTM1 interactions | TRAF1 KIF23 CHAF1A PSMC5 PSMD3 CC2D1A TRIM21 SSB RB1CC1 STAT5A TFRC CEP350 SLC38A2 IGF2BP3 DNAJC10 SYNJ2 FARP1 CEP250 BUB1 XRN1 AGFG1 HSPA8 DYNC1H1 | 2.22e-04 | 1257 | 164 | 23 | int:SQSTM1 |
| Interaction | DCTN1 interactions | TPR KRT3 SPTBN2 MED14 CC2D1A CEP350 KRT76 DST SYNJ2 ANKRD28 MACF1 HSPA8 DYNC1H1 | 2.22e-04 | 497 | 164 | 13 | int:DCTN1 |
| Interaction | NSUN5P2 interactions | 2.24e-04 | 15 | 164 | 3 | int:NSUN5P2 | |
| Interaction | GNB2 interactions | KIF23 COPG1 PSMC5 PFDN2 STAT5A TMEM33 PDRG1 LRP1 SGO2 HSPA2 HSPA6 HSPA8 DCAF12 | 2.44e-04 | 502 | 164 | 13 | int:GNB2 |
| Interaction | SNCA interactions | TPP2 TPR ILK CENPF PSMD3 APOA1 PFDN2 SSB IGF2BP3 DST SUGP2 FARP1 XRN1 MACF1 HSPA8 DYNC1H1 | 2.54e-04 | 716 | 164 | 16 | int:SNCA |
| Interaction | AGBL4 interactions | 2.65e-04 | 70 | 164 | 5 | int:AGBL4 | |
| Interaction | KCNA3 interactions | ADCY10 TPR ABCA13 LZTFL1 PSMC5 PSMD3 CC2D1A PPL TMEM33 EHD3 TFRC DST XRN1 MACF1 TRPM1 RP1 HSPA8 DYNC1H1 | 2.69e-04 | 871 | 164 | 18 | int:KCNA3 |
| Interaction | HTT interactions | ATP5PB KIF21B TPR CACNA2D1 KIF23 HCN1 PSMC5 PSMD3 SSB BCAR1 TRIP10 EHD3 TEKT2 DST ZNF451 HSPA2 HSPA8 DYNC1H1 LGI1 | 2.70e-04 | 949 | 164 | 19 | int:HTT |
| Interaction | PRODH interactions | 2.74e-04 | 16 | 164 | 3 | int:PRODH | |
| Interaction | DNAJC5 interactions | SPTBN2 TMEM33 TFRC SLC38A2 DNAJC10 FARP1 AGFG1 MACF1 HSPA2 HSPA8 TPD52 | 2.78e-04 | 378 | 164 | 11 | int:DNAJC5 |
| Interaction | LAMTOR1 interactions | DENND4A SPTBN2 LMTK2 CC2D1A SNX29 TFRC RUFY2 SLC38A2 DST FARP1 AGFG1 PPP1R37 EEA1 VPS53 HSPA8 TPD52 | 2.78e-04 | 722 | 164 | 16 | int:LAMTOR1 |
| Interaction | KIF23 interactions | KIF23 RPGRIP1L ILK ABCA13 TUT7 SSB RALGAPA2 IGF2BP3 ELL2 DNAJC10 SUGP2 CEBPZ FARP1 ZNF451 CEP250 PTCD2 MACF1 FBXO21 HSPA8 DYNC1H1 | 2.79e-04 | 1031 | 164 | 20 | int:KIF23 |
| GeneFamily | EF-hand domain containing|Plakins | 1.44e-05 | 8 | 117 | 3 | 939 | |
| GeneFamily | Heat shock 70kDa proteins | 1.68e-04 | 17 | 117 | 3 | 583 | |
| GeneFamily | Exportins | 8.54e-04 | 7 | 117 | 2 | 547 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 1.16e-03 | 181 | 117 | 6 | 694 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL | KIF21B KIF23 CENPF ATAD5 CHAF1A KCMF1 FAXC APOA1 DEPDC1 DDC TFRC C5orf34 SYNJ2 BUB1 GPSM2 SGO2 RAB11FIP4 HSPA2 HSPA6 | 3.17e-09 | 567 | 164 | 19 | M45692 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | TBX15 RAD51B TPP2 ILK TUT7 CRPPA PFDN2 CHD7 SSB NRN1 SNX29 SLC38A2 DNAJC10 CEBPZ MYLIP XRN1 PTCD2 FLRT2 MYO18B FBXO21 PLCE1 XPO7 | 3.64e-07 | 1009 | 164 | 22 | M157 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL | KIF23 CENPF ATAD5 CHAF1A DEPDC1 DDC ZWINT IGF2BP3 BUB1 GPSM2 SGO2 LGI1 | 9.53e-07 | 322 | 164 | 12 | M39060 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP | 1.41e-06 | 127 | 164 | 8 | M40905 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TBX15 TPR APOA1 USP16 TMEM33 TFRC RTF1 SLC38A2 ELL2 GLYR1 BUB1 ANKRD28 SGO2 ANAPC5 | 5.25e-06 | 519 | 164 | 14 | M3395 |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_3_UP | KIF23 CENPF CHAF1A DEPDC1 ST8SIA3 FAM200B ZWINT TFRC BUB1 RAB11FIP4 XPOT | 7.48e-06 | 328 | 164 | 11 | M854 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KIF23 CENPF LAMC1 RB1CC1 PHF8 CEP350 EVI5 TRIM33 IGF2BP3 ELL2 DST SYNJ2 ZNF451 AGFG1 ANKRD28 MACF1 FLRT2 PLCE1 | 7.49e-06 | 856 | 164 | 18 | M4500 |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | TBX15 TPR APOA1 USP16 TMEM33 TFRC RTF1 SLC38A2 ELL2 GLYR1 BUB1 ANKRD28 SGO2 ANAPC5 | 8.75e-06 | 543 | 164 | 14 | MM997 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | TPR CENPF DEPDC1 SSB USP16 B4GALT5 TFRC SLC38A2 C5orf34 IGF2BP3 DNAJC10 PDRG1 CEBPZ XRN1 SGO2 XPOT | 1.28e-05 | 721 | 164 | 16 | M10237 |
| Coexpression | GEORGES_TARGETS_OF_MIR192_AND_MIR215 | KIF23 RPGRIP1L CENPF ATAD5 FAXC DEPDC1 CHD7 COPS7A C5orf34 ELL2 DST CUZD1 GPSM2 MACF1 SGO2 EEA1 HSPA2 PLCE1 | 1.31e-05 | 892 | 164 | 18 | M18120 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL | 1.65e-05 | 232 | 164 | 9 | M45800 | |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP | 1.78e-05 | 179 | 164 | 8 | M3268 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_UP | 2.26e-05 | 185 | 164 | 8 | M374 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | TBX15 RAD51B TUT7 CHD7 SNX29 SLC38A2 CEBPZ MYLIP XRN1 PTCD2 MYO18B FBXO21 | 2.32e-05 | 441 | 164 | 12 | M172 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | CACNA2D1 KIF23 CENPF ORC3 CHAF1A LAMC1 PFDN2 DEPDC1 ZNF112 TMEM33 ZWINT TFRC C5orf34 GBP5 PDRG1 NBPF9 BUB1 GPSM2 SGO2 WDSUB1 ANAPC5 VPS53 XPOT | 2.36e-05 | 1407 | 164 | 23 | M14427 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP | 2.44e-05 | 187 | 164 | 8 | M2984 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TPP2 DENND4A MED14 CHD7 ARMCX5 RB1CC1 RALGAPA2 USP16 MBIP ELL2 CEBPZ ZNF451 MYLIP ANKRD28 FBXO21 | 2.59e-05 | 680 | 164 | 15 | M41089 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST | KIF23 CENPF ATAD5 CHAF1A DEPDC1 ZWINT TFRC BLVRA ELL2 BUB1 GPSM2 SGO2 | 2.83e-05 | 450 | 164 | 12 | M45747 |
| Coexpression | WHITFIELD_CELL_CYCLE_G2_M | 3.68e-05 | 198 | 164 | 8 | M2077 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL | 3.70e-05 | 145 | 164 | 7 | M45693 | |
| Coexpression | GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN | 3.81e-05 | 199 | 164 | 8 | M9398 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 3.81e-05 | 199 | 164 | 8 | M5893 | |
| Coexpression | GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN | 3.95e-05 | 200 | 164 | 8 | M9533 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN | 3.95e-05 | 200 | 164 | 8 | M5130 | |
| Coexpression | GSE7852_LN_VS_FAT_TREG_DN | 3.95e-05 | 200 | 164 | 8 | M5742 | |
| Coexpression | BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP | 5.08e-05 | 12 | 164 | 3 | M34000 | |
| Coexpression | FAN_EMBRYONIC_CTX_MICROGLIA_1 | 5.65e-05 | 155 | 164 | 7 | M39041 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | TPR CENPF USP16 FAM200B ZWINT TFRC EVI5 C5orf34 IGF2BP3 DNAJC10 CEBPZ AGFG1 GPSM2 SGO2 | 5.69e-05 | 644 | 164 | 14 | M10501 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KIF23 ORC3 TUT7 DEPDC1 SSB RB1CC1 CEP350 SLC38A2 TRIM33 CEBPZ TRPM1 EEA1 CPLANE1 TPD52 | 6.93e-05 | 656 | 164 | 14 | M18979 |
| Coexpression | PATIL_LIVER_CANCER | TPR KIF23 CENPF ORC3 CHAF1A LMTK2 RB1CC1 ZWINT BUB1 GPSM2 DYNC1H1 TPD52 XPOT XPO7 | 7.39e-05 | 660 | 164 | 14 | M1195 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL | 7.96e-05 | 221 | 164 | 8 | M45789 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM | 8.30e-05 | 354 | 164 | 10 | M39061 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | CACNA2D1 ORC3 KCMF1 ANO5 CHD7 ST8SIA3 FAM200B SNX29 PPL TMEM33 COPS7A DST UNC79 HSPA8 DYNC1H1 TPD52 XPOT | 9.63e-05 | 946 | 164 | 17 | M39169 |
| Coexpression | GARY_CD5_TARGETS_DN | TPR KIF23 CENPF PSMC5 USP16 TMEM33 ZWINT TFRC DNAJC10 CEBPZ ZNF451 | 1.09e-04 | 440 | 164 | 11 | M13893 |
| Coexpression | GSE6259_DEC205_POS_DC_VS_BCELL_DN | 1.09e-04 | 172 | 164 | 7 | M6772 | |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | TPP2 SSB USP16 ZWINT TFRC ELL2 DNAJC10 CEBPZ ZNF451 ANKRD28 EEA1 CMTR2 TPD52 XPOT | 1.13e-04 | 687 | 164 | 14 | M41022 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP | 1.17e-04 | 174 | 164 | 7 | M40888 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN | 1.17e-04 | 174 | 164 | 7 | M2996 | |
| Coexpression | GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP | 1.25e-04 | 176 | 164 | 7 | M2981 | |
| Coexpression | FISCHER_G2_M_CELL_CYCLE | 1.25e-04 | 236 | 164 | 8 | M130 | |
| Coexpression | LINDGREN_BLADDER_CANCER_CLUSTER_1_DN | KIF21B KIF23 CENPF DEPDC1 ST8SIA3 STAT5B ZWINT TFRC BUB1 SGO2 | 1.42e-04 | 378 | 164 | 10 | M17788 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP | 1.44e-04 | 180 | 164 | 7 | M8127 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 1.44e-04 | 180 | 164 | 7 | M8239 | |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | RPGRIP1L ABCA13 SYNE1 LZTFL1 DNAH7 SNX29 TEKT2 DNAH12 MACF1 CPLANE1 CFAP44 | 1.57e-04 | 459 | 164 | 11 | M39136 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 1.61e-04 | 384 | 164 | 10 | M1865 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.86e-04 | 250 | 164 | 8 | M11318 | |
| Coexpression | TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN | 1.87e-04 | 132 | 164 | 6 | M15410 | |
| Coexpression | ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN | 1.96e-04 | 46 | 164 | 4 | M6792 | |
| Coexpression | FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN | 2.01e-04 | 190 | 164 | 7 | M761 | |
| Coexpression | ZHONG_PFC_C1_MICROGLIA | 2.24e-04 | 257 | 164 | 8 | M39103 | |
| Coexpression | BENPORATH_CYCLING_GENES | KIF23 CENPF ORC3 CHAF1A USP16 STAT5B ZWINT SLC38A2 BUB1 AGFG1 GPSM2 CPLANE1 HSPA8 | 2.31e-04 | 648 | 164 | 13 | M8156 |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 2.33e-04 | 402 | 164 | 10 | MM1248 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KIF23 CENPF ATAD5 CHAF1A DEPDC1 GCNT4 BUB1 GPSM2 ANKRD28 SGO2 | 2.33e-04 | 402 | 164 | 10 | MM454 |
| Coexpression | GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP | 2.43e-04 | 196 | 164 | 7 | M6227 | |
| Coexpression | ODONNELL_TFRC_TARGETS_DN | 2.48e-04 | 139 | 164 | 6 | M6451 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP | 2.51e-04 | 197 | 164 | 7 | M5867 | |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 2.51e-04 | 197 | 164 | 7 | M5210 | |
| Coexpression | GSE3982_DC_VS_NKCELL_DN | 2.51e-04 | 197 | 164 | 7 | M5480 | |
| Coexpression | GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN | 2.58e-04 | 198 | 164 | 7 | M6224 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN | 2.67e-04 | 199 | 164 | 7 | M4571 | |
| Coexpression | GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN | 2.67e-04 | 199 | 164 | 7 | M3669 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN | 2.67e-04 | 199 | 164 | 7 | M7511 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN | 2.67e-04 | 199 | 164 | 7 | M5230 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 2.67e-04 | 199 | 164 | 7 | M5486 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 2.75e-04 | 200 | 164 | 7 | M7031 | |
| Coexpression | GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN | 2.75e-04 | 200 | 164 | 7 | M9628 | |
| Coexpression | GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP | 2.75e-04 | 200 | 164 | 7 | M8653 | |
| Coexpression | GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP | 2.75e-04 | 200 | 164 | 7 | M7649 | |
| Coexpression | KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP | 2.75e-04 | 200 | 164 | 7 | M3030 | |
| Coexpression | GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN | 2.75e-04 | 200 | 164 | 7 | M3067 | |
| Coexpression | GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP | 2.75e-04 | 200 | 164 | 7 | M6947 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP | 3.11e-04 | 145 | 164 | 6 | M3045 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | 3.11e-04 | 341 | 164 | 9 | M2879 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | TPP2 CENPF CHAF1A PSMD3 SSB RB1CC1 STAT5A ZWINT TFRC KRT76 CEBPZ BUB1 ANAPC5 HSPA8 | 3.21e-04 | 761 | 164 | 14 | M11961 |
| Coexpression | BENPORATH_PROLIFERATION | 3.35e-04 | 147 | 164 | 6 | M2114 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | KIF23 CENPF ATAD5 CHAF1A MED14 FAXC DEPDC1 CHD7 DDC SLC38A2 ANKRD28 SGO2 UNC79 | 3.67e-04 | 680 | 164 | 13 | MM456 |
| Coexpression | GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP | 4.00e-04 | 152 | 164 | 6 | M343 | |
| Coexpression | GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP | 4.00e-04 | 152 | 164 | 6 | M2964 | |
| Coexpression | GSE11818_WT_VS_DICER_KO_TREG_DN | 4.29e-04 | 154 | 164 | 6 | M411 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | 4.58e-04 | 438 | 164 | 10 | M227 | |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_DN | 4.61e-04 | 102 | 164 | 5 | M5601 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | KIF23 CENPF CHAF1A CHD7 SSB RB1CC1 DDC TFRC DNAJC10 BUB1 AGFG1 XPO7 | 4.94e-04 | 612 | 164 | 12 | M4772 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL | 5.02e-04 | 290 | 164 | 8 | M45736 | |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 5.42e-04 | 161 | 164 | 6 | M7728 | |
| Coexpression | WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN | 5.72e-04 | 371 | 164 | 9 | M2132 | |
| Coexpression | GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP | 5.79e-04 | 163 | 164 | 6 | M6763 | |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP | TRAF1 TRIP10 B4GALT5 STAT5A CEP350 TMCO2 MACF1 DYNC1H1 EVI5L TPD52 | 5.84e-04 | 452 | 164 | 10 | M18685 |
| Coexpression | FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP | 5.98e-04 | 164 | 164 | 6 | M19957 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNPROG | 6.18e-04 | 229 | 164 | 7 | M39062 | |
| Coexpression | VANTVEER_BREAST_CANCER_METASTASIS_DN | 6.24e-04 | 109 | 164 | 5 | M9826 | |
| CoexpressionAtlas | alpha beta T cells, NKT.44-NK1.1-.Th, aGC CD1d tet CD3e, Thymus, avg-2 | KIF23 CENPF ATAD5 LZTFL1 MED14 DEPDC1 EHD3 TFRC IGF2BP3 FARP1 BUB1 AGFG1 SGO2 | 1.29e-05 | 398 | 163 | 13 | GSM538338_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | RPGRIP1L CENPF TUT7 CHD7 SSB RB1CC1 B4GALT5 EHD3 RUFY2 EVI5 C5orf34 CEP250 TXNDC16 MACF1 EEA1 CPLANE1 ANAPC5 VPS53 | 3.23e-05 | 780 | 163 | 18 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | KIF23 CENPF ATAD5 CHAF1A DEPDC1 SNX29 ELL2 BUB1 TXNDC16 GPSM2 SGO2 DCAF12 | 3.90e-05 | 380 | 163 | 12 | GSM538207_500 |
| CoexpressionAtlas | B cells, preB.FrD.FL, AA4.1+ IgM- CD19+ CD43- CD24+, Fetal Liver, avg-3 | CACNA2D1 KIF23 CENPF ATAD5 LAMC1 DEPDC1 SNX29 TFRC IGF2BP3 BUB1 SGO2 TPD52 | 5.66e-05 | 395 | 163 | 12 | GSM538340_500 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.LisOva, CD8+ CD45.1+, Spleen, avg-3 | KIF23 CENPF ATAD5 CHAF1A LAMC1 DEPDC1 CHD7 B4GALT5 EHD3 BUB1 GPSM2 SGO2 | 6.69e-05 | 402 | 163 | 12 | GSM605898_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | KIF23 CENPF ATAD5 CHAF1A DEPDC1 TFRC IGF2BP3 FARP1 BUB1 GPSM2 SGO2 PLCE1 | 9.90e-05 | 419 | 163 | 12 | GSM476664_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | RAD51B KIF23 CENPF ATAD5 CHAF1A LZTFL1 DEPDC1 TFRC IGF2BP3 BUB1 ANKRD28 SGO2 | 1.06e-04 | 422 | 163 | 12 | GSM538355_500 |
| CoexpressionAtlas | alpha beta T cells, T.8.TI.B16, 4- 8+ TCR+ 45+, B16 Melanoma Tumor, avg-2 | DENND4A LAMC1 DEPDC1 NRN1 B4GALT5 EHD3 TFRC FARP1 BUB1 SGO2 EEA1 | 1.08e-04 | 359 | 163 | 11 | GSM605773_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3 | KIF21B KIF23 CENPF ATAD5 LZTFL1 DEPDC1 GCNT4 EHD3 TFRC RTF1 BUB1 SGO2 | 1.08e-04 | 423 | 163 | 12 | GSM476655_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | TPP2 TPR CACNA2D1 MED14 LAMC1 TMEM33 STAT5B TFRC RUFY2 CEP350 CPLANE1 | 1.37e-04 | 369 | 163 | 11 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.71e-04 | 316 | 163 | 10 | gudmap_kidney_P3_CapMes_Crym_k4_1000 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | KIF23 RPGRIP1L CENPF LZTFL1 DEPDC1 TEKT2 DNAH12 BUB1 SGO2 PLCE1 | 1.49e-09 | 180 | 165 | 10 | 0c146e80d55d18b6988dd21b1da635801bd3140c |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | KIF23 RPGRIP1L CENPF LZTFL1 DEPDC1 TEKT2 DNAH12 BUB1 SGO2 PLCE1 | 1.49e-09 | 180 | 165 | 10 | e9af22beae2f3c7fe213b4e19df84abfd2453433 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | KIF23 RPGRIP1L CENPF LZTFL1 DEPDC1 TEKT2 DNAH12 BUB1 SGO2 PLCE1 | 1.49e-09 | 180 | 165 | 10 | 11455ba704ac73f69b474845136cfecec6a88349 |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | TPP2 KIF23 CENPF CHAF1A DEPDC1 CEP350 BUB1 ANKRD28 SGO2 PLCE1 | 3.08e-09 | 194 | 165 | 10 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.01e-08 | 190 | 165 | 9 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.01e-08 | 190 | 165 | 9 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.59e-08 | 193 | 165 | 9 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.59e-08 | 193 | 165 | 9 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.71e-08 | 198 | 165 | 9 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 5.97e-08 | 199 | 165 | 9 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Mild/Remission-Developping_Plasmablast|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 5.97e-08 | 199 | 165 | 9 | 1dda6116de639140c2d6f5012b7ab9ad0f737ae1 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells-Neuroepithelial_cell|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.23e-08 | 200 | 165 | 9 | c865efaaaecccbf9c833d6c1cbe85809a3ec306d | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | ce8281c9556a1f64f8ca8a029110077d4ef5b35e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Stem_cells|5w / Sample Type, Dataset, Time_group, and Cell type. | 6.23e-08 | 200 | 165 | 9 | 2ee167b8bddd11fd5b1f61f87fcdf757aee3193e | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.23e-08 | 200 | 165 | 9 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.23e-08 | 200 | 165 | 9 | 9c03a8da12d29618f72c429836c1d1bd84a78b12 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-08 | 200 | 165 | 9 | 43571c9284d4e41402a2d1eefc1efe2ce8476d4a | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 6.23e-08 | 200 | 165 | 9 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.23e-08 | 200 | 165 | 9 | 63f9481059be608ddc9fe9c7a8f8503fce9755dd | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega-Erythroid|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | 83c4181c083b364f0d3a89ae7a0504781fa9fa9f | |
| ToppCell | LPS_only-Hematopoietic_Erythro-Megakary-Erythro-Mega|LPS_only / Treatment groups by lineage, cell group, cell type | 6.23e-08 | 200 | 165 | 9 | f15baf287ec467664c23faa53fdea45257f7b9d0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-07 | 174 | 165 | 8 | dbb4e1a6c3319ce40f81bfd2d1745a88a2cc412e | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-07 | 175 | 165 | 8 | 73f25bd54309aed1480ddc44bdab518b17e71f92 | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.47e-07 | 178 | 165 | 8 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5|TCGA-Liver / Sample_Type by Project: Shred V9 | 4.28e-07 | 183 | 165 | 8 | f604a8b62c7088fad8365dbf8d910fc980bd3ba8 | |
| ToppCell | Control-T/NK_proliferative|Control / Disease group and Cell class | 4.28e-07 | 183 | 165 | 8 | 09c2b4e630f1c338f02c1242e3598e870d6b0a28 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-07 | 183 | 165 | 8 | 6c1d7ce60e67bf1df364a4e177c351e7313eb41f | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 4.65e-07 | 185 | 165 | 8 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-07 | 185 | 165 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | COVID-CD4-CD8_1|COVID / Condition, Cell_class and T cell subcluster | 4.65e-07 | 185 | 165 | 8 | c634bb04a081ae3214b68f6e4a147db5b2b916ed | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-07 | 186 | 165 | 8 | 3993f1ef8a33b8a75dfd3db8d4845b5afbb0bb3d | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.84e-07 | 186 | 165 | 8 | ec6d0c29e196e374baa96dd3d506f489c959e77e | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.25e-07 | 188 | 165 | 8 | b3cae49f0665ace0016a6441cbf9ae40755b0ea3 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.46e-07 | 189 | 165 | 8 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.46e-07 | 189 | 165 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | NS-critical-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.69e-07 | 190 | 165 | 8 | 7be0f2ff86ca8500a43e0d44e5e292530f9ba0bb | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-07 | 191 | 165 | 8 | 15dbc5a03bfab8931c0fd385b0f25874736ae874 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 5.92e-07 | 191 | 165 | 8 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 5.92e-07 | 191 | 165 | 8 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Cycling_T|GI_small-bowel / Manually curated celltypes from each tissue | 5.92e-07 | 191 | 165 | 8 | e642fa7395c05fb53324c9d46bbc52f89fc9673f | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.92e-07 | 191 | 165 | 8 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-Proliferating_T_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.92e-07 | 191 | 165 | 8 | 45c15f5ce4a207ac944bed65d45f06c1657d1a6d | |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.40e-07 | 193 | 165 | 8 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating-T_cells_proliferating_L.1.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.40e-07 | 193 | 165 | 8 | b835d28de9daeec5213172c96f62b332cda53bb5 | |
| ToppCell | severe-B_cell|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.66e-07 | 194 | 165 | 8 | 2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.66e-07 | 194 | 165 | 8 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.66e-07 | 194 | 165 | 8 | 5dffa578149104dda33774361e9e77b227b5f1ce | |
| ToppCell | (1)_T_cells_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.66e-07 | 194 | 165 | 8 | 8f313071933451780309d2174ed27d8cdc734343 | |
| ToppCell | 3'-Distal_airway-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.66e-07 | 194 | 165 | 8 | 6cc689595a182fbf685fa2f3b9c300f7170fb81f | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.66e-07 | 194 | 165 | 8 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell-T_cells_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-07 | 195 | 165 | 8 | 67670d16ddd5d5ab7bc2254df329f5a7b2581556 | |
| ToppCell | Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.92e-07 | 195 | 165 | 8 | 79ee423df85aa1631b7bdea74eacaf826dfc4a2c | |
| ToppCell | Dividing_cells-Dividing_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.92e-07 | 195 | 165 | 8 | 19829760dfcc0edafd2a2bd80f424a45d039af1f | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|B_lymphocytes / Location, Cell class and cell subclass | 6.92e-07 | 195 | 165 | 8 | 339e81a3a5b1f71c0d15ef1ef0f6999378704923 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_T/NK-T_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.92e-07 | 195 | 165 | 8 | 23dc2f8a3a038195a31feee7e3a51094a7a7c23e | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-07 | 195 | 165 | 8 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.92e-07 | 195 | 165 | 8 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.92e-07 | 195 | 165 | 8 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.92e-07 | 195 | 165 | 8 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.92e-07 | 195 | 165 | 8 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.92e-07 | 195 | 165 | 8 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-07 | 195 | 165 | 8 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.97e-07 | 134 | 165 | 7 | 4d8f7ddad02fe76a614771e115ebb8e04623ba85 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-07 | 196 | 165 | 8 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 196 | 165 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 7.19e-07 | 196 | 165 | 8 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 196 | 165 | 8 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.19e-07 | 196 | 165 | 8 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.19e-07 | 196 | 165 | 8 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.47e-07 | 197 | 165 | 8 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| ToppCell | severe_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 7.47e-07 | 197 | 165 | 8 | 189d97a6c2ff8803db8cc05e205c9d88dac3911f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.47e-07 | 197 | 165 | 8 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.47e-07 | 197 | 165 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.47e-07 | 197 | 165 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-Cycling_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 7.76e-07 | 198 | 165 | 8 | b2868a897dd96494cf1829c30e0ce508f52efdf3 | |
| ToppCell | (4)_B_cells-(4)_B_Hypermutation|(4)_B_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.76e-07 | 198 | 165 | 8 | 8be724a49b4c911d68c3e82fb75e96722d0eaa03 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 7.76e-07 | 198 | 165 | 8 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 7.76e-07 | 198 | 165 | 8 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 7.76e-07 | 198 | 165 | 8 | 6a10bb81817ab606f1f5a2bd8cfe77ef2fb3f2fb | |
| ToppCell | normal_Lung-T/NK_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 7.76e-07 | 198 | 165 | 8 | c65cdb54409087014125a76627e5efb5fe8dabc9 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.76e-07 | 198 | 165 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.76e-07 | 198 | 165 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | distal-1-Hematologic-Proliferating_Macrophage|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.76e-07 | 198 | 165 | 8 | df3f5559ecd1f3cd1fd60e39dbad8741309e83a3 | |
| ToppCell | distal-Hematologic-Proliferating_Macrophage-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.76e-07 | 198 | 165 | 8 | 2b0716e900bce54ad1825d6dcdaf4ebf31f355c4 | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|World / disease group, cell group and cell class | 7.76e-07 | 198 | 165 | 8 | 48045689d0969ff0a14eee7086b8e19b0d6b6065 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 7.76e-07 | 198 | 165 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.76e-07 | 198 | 165 | 8 | 6981cd5b1585c8ae6febdf0c4fb83067127f106c | |
| ToppCell | (0)_NK_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 7.76e-07 | 198 | 165 | 8 | c5336d9b802393d6fd6f8446ea4bb6befeb97bfd | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.76e-07 | 198 | 165 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.06e-07 | 199 | 165 | 8 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 8.06e-07 | 199 | 165 | 8 | 5c8b847b794b3e88722f5b841f2539a27251106c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.06e-07 | 199 | 165 | 8 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.06e-07 | 199 | 165 | 8 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.06e-07 | 199 | 165 | 8 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.06e-07 | 199 | 165 | 8 | 7816ad127b16208b1046da53f4a295b4a747b4cc | |
| ToppCell | tumor_Lung-T/NK_cells-Undetermined|tumor_Lung / Location, Cell class and cell subclass | 8.06e-07 | 199 | 165 | 8 | 2e222e2e080bc2be63d0fdf285e1790676b911ef | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.06e-07 | 199 | 165 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | 10x5'-Lung-Myeloid_Mac-Cycling_Myeloid-Mac|Lung / Manually curated celltypes from each tissue | 8.06e-07 | 199 | 165 | 8 | dee1cf8ee850a2bd57349418a9bcc0948fe9ac9e | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.06e-07 | 199 | 165 | 8 | 4af38f5e9d2229d64f7ecdf9c00b4d67e5f86a51 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.06e-07 | 199 | 165 | 8 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| Disease | neutrophil gelatinase-associated lipocalin measurement | 1.51e-07 | 3 | 158 | 3 | EFO_0021964 | |
| Disease | sick sinus syndrome (implicated_via_orthology) | 8.52e-05 | 3 | 158 | 2 | DOID:13884 (implicated_via_orthology) | |
| Disease | Cerebellar Ataxia | 2.82e-04 | 5 | 158 | 2 | C0007758 | |
| Disease | cerebellar ataxia (is_implicated_in) | 2.82e-04 | 5 | 158 | 2 | DOID:0050753 (is_implicated_in) | |
| Disease | Dengue Hemorrhagic Fever | 5.88e-04 | 7 | 158 | 2 | EFO_0004227 | |
| Disease | Malignant neoplasm of breast | RAD51B CENPF SYNE1 MED14 BCAR1 RB1CC1 STAT5A TFRC C5orf34 NLRP9 KRT76 SYNJ2 FARP1 MACF1 ANAPC5 | 6.83e-04 | 1074 | 158 | 15 | C0006142 |
| Disease | migraine disorder | 7.09e-04 | 357 | 158 | 8 | MONDO_0005277 | |
| Disease | cortical surface area measurement | RAD51B CACNA2D1 CHAF1A TUT7 CRPPA LAMC1 CHD7 DNAH7 COPS7A BLVRA EVI5 SLC38A2 XRN1 AGFG1 MACF1 RAB11FIP4 PLCE1 | 9.15e-04 | 1345 | 158 | 17 | EFO_0010736 |
| Disease | Developmental delay (disorder) | 1.02e-03 | 37 | 158 | 3 | C0424605 | |
| Disease | prostate carcinoma | RAD51B CACNA2D1 LMTK2 LAMC1 CHD7 ZNF112 PPL CEP350 GJB1 DNAH12 CFAP44 VPS53 TPD52 | 1.06e-03 | 891 | 158 | 13 | EFO_0001663 |
| Disease | factor VIII measurement | 1.29e-03 | 40 | 158 | 3 | EFO_0004630 | |
| Disease | HVA measurement, MHPG measurement | 1.29e-03 | 40 | 158 | 3 | EFO_0005131, EFO_0005133 | |
| Disease | Combined immunodeficiency | 1.38e-03 | 41 | 158 | 3 | C0494261 | |
| Disease | Ductal Carcinoma | 1.52e-03 | 11 | 158 | 2 | C1176475 | |
| Disease | gastric adenocarcinoma (is_implicated_in) | 1.52e-03 | 11 | 158 | 2 | DOID:3717 (is_implicated_in) | |
| Disease | Liver carcinoma | 1.71e-03 | 507 | 158 | 9 | C2239176 | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.82e-03 | 12 | 158 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 1.85e-03 | 616 | 158 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.85e-03 | 616 | 158 | 10 | C0376358 | |
| Disease | Brugada Syndrome 1 | 2.14e-03 | 13 | 158 | 2 | C4551804 | |
| Disease | Alzheimer disease, educational attainment | 2.21e-03 | 247 | 158 | 6 | EFO_0011015, MONDO_0004975 | |
| Disease | multiple sclerosis (is_marker_for) | 2.32e-03 | 49 | 158 | 3 | DOID:2377 (is_marker_for) | |
| Disease | Malignant mesothelioma | 2.85e-03 | 109 | 158 | 4 | C0345967 | |
| Disease | P wave duration | 2.86e-03 | 15 | 158 | 2 | EFO_0005094 | |
| Disease | multiple myeloma | 3.14e-03 | 112 | 158 | 4 | EFO_0001378 | |
| Disease | apolipoprotein B measurement | CACNA2D1 APOA1 ZNF112 GCNT4 EVI5 MYLIP SUGP1 PPP1R37 GPSM2 RP1 | 3.14e-03 | 663 | 158 | 10 | EFO_0004615 |
| Disease | diastolic blood pressure, systolic blood pressure | 3.38e-03 | 670 | 158 | 10 | EFO_0006335, EFO_0006336 | |
| Disease | Carcinoma, Granular Cell | 3.56e-03 | 116 | 158 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.56e-03 | 116 | 158 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.56e-03 | 116 | 158 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.56e-03 | 116 | 158 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.56e-03 | 116 | 158 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.56e-03 | 116 | 158 | 4 | C0001418 | |
| Disease | Polydactyly | 3.67e-03 | 117 | 158 | 4 | C0152427 | |
| Disease | cervical artery dissection | 3.68e-03 | 17 | 158 | 2 | EFO_1000059 | |
| Disease | phosphatidylcholine measurement | 4.38e-03 | 284 | 158 | 6 | EFO_0010226 | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 4.39e-03 | 123 | 158 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | atopic asthma | 4.45e-03 | 199 | 158 | 5 | EFO_0010638 | |
| Disease | Brugada syndrome | 4.59e-03 | 19 | 158 | 2 | MONDO_0015263 | |
| Disease | Omenn Syndrome | 4.59e-03 | 19 | 158 | 2 | C2700553 | |
| Disease | Headache | 4.94e-03 | 64 | 158 | 3 | HP_0002315 | |
| Disease | mood instability measurement | 5.05e-03 | 128 | 158 | 4 | EFO_0008475 | |
| Disease | Familial aplasia of the vermis | 5.08e-03 | 20 | 158 | 2 | cv:C0431399 | |
| Disease | non-high density lipoprotein cholesterol measurement | 5.21e-03 | 713 | 158 | 10 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LLNQLDGFEATKNIK | 276 | P62195 | |
| LLENNKGIKNSFEQK | 1256 | Q96QE3 | |
| FSILNELSLKLQGKN | 436 | P0CF97 | |
| ALQEKLQYLAAQNKG | 606 | Q96CN4 | |
| KDKNSLGAILQQVAN | 236 | O00472 | |
| LNKLKENLGINSNEF | 881 | Q75V66 | |
| QGDLNDAKNKQKFVL | 806 | O43683 | |
| KVTGQNQEQFLLLAK | 6 | Q9UBW8 | |
| NQEQFLLLAKSAKGA | 11 | Q9UBW8 | |
| QGKSQLELQQLKQFE | 691 | P56945 | |
| LVLDVAQKAQNLFGK | 301 | Q6IC98 | |
| GDLFLKLTNDENNFL | 341 | A8MVX0 | |
| LNLLLNTGADFNKKD | 421 | O15084 | |
| NAFLDLKNSLNEVKN | 61 | Q8IYT2 | |
| VNKSEDLFKLNQDLG | 2396 | Q86UQ4 | |
| QFEGSALGKQLNLKL | 56 | P02647 | |
| AGRVNIQDLQKNKFL | 1586 | Q96PN6 | |
| DQQGLLKAIQNDKLA | 156 | Q13111 | |
| FRLKGSNKVNEALLQ | 411 | P20711 | |
| KSKERQGLDGLNNLN | 346 | O43286 | |
| KKAELDIDALNGRNN | 1536 | Q9P2D1 | |
| AGNQLIFLNLKTKEQ | 161 | Q96MT7 | |
| SLNNDQLLKGDFRLQ | 611 | O43155 | |
| FQEAKQFGQKLQDLA | 526 | Q6P1M9 | |
| ADFADKLNEQKLAQL | 121 | P24539 | |
| LLQKSDNSFNQELLK | 1751 | Q7Z401 | |
| LKGFNLNPLNQDELK | 111 | Q9NUG6 | |
| DAQLQGNLKERNKFL | 221 | O15315 | |
| FKNGDINADFSQLKL | 756 | Q6ZP01 | |
| NGDLKSKLKQENTQL | 361 | Q86YS3 | |
| LQEAQNNLKIFKNGE | 201 | Q9H8X2 | |
| FNGLKALAEDQINSK | 131 | A4D126 | |
| KDANAKLQDLQTALQ | 441 | Q01546 | |
| LKNLKDLNLAGNLIN | 141 | Q6ZRR7 | |
| LKEDNLLFQNNLNKV | 951 | Q86VD1 | |
| LQKELNNLLKFNPDF | 236 | Q9UJX4 | |
| QKELAQGFLANQKRA | 386 | Q8TDY2 | |
| QGFLANQKRAENLKD | 391 | Q8TDY2 | |
| QKILNNLKAFLQQPD | 176 | O94952 | |
| FLEEKLGVNLNKNLG | 166 | Q5TGI0 | |
| VLKDLNFQGKTINLG | 241 | Q5T9C9 | |
| GLKDFLQNNALLEFK | 661 | P81274 | |
| LQNNALLEFKNSGKK | 666 | P81274 | |
| EKALQDLQLDQGNQK | 186 | Q9NQ48 | |
| DLQLDQGNQKDFIKA | 191 | Q9NQ48 | |
| QGNQKDFIKAQDLSN | 196 | Q9NQ48 | |
| AKDANNGNLQLRNKE | 286 | P05455 | |
| IKAQKEQKNGDLSFL | 466 | Q68CZ1 | |
| NTENFLKENGEKLSQ | 3706 | Q03001 | |
| LLKQGLNNAVALDFD | 3051 | Q07954 | |
| ALKDANAKLQELQAA | 456 | P12035 | |
| KLLQDFFNGKELNKS | 351 | P54652 | |
| QQLQAKGKELNEFRE | 106 | Q9UHV9 | |
| LVEEKLDKLNNQSFG | 141 | O60437 | |
| LQEKVQYLSAQNKGL | 611 | O60447 | |
| NFLKASIDKGLQVAQ | 1036 | O75037 | |
| FLDQKCQNILQGNFK | 481 | Q49A26 | |
| PNIEGQNNKLFLESK | 446 | Q5TB30 | |
| TNKAKAFANILLNDI | 481 | Q6ZR08 | |
| LASLFLNENINLGKK | 296 | Q8WY64 | |
| ENFLFLQEKNLLKGS | 721 | Q8IWU2 | |
| KESKNLNIQGSLFEL | 96 | Q9NPD7 | |
| KADNKNDIQIFALAL | 106 | Q96PP8 | |
| NKLLQLELNDEFIGN | 361 | Q6IE36 | |
| NFIALENSLKLKGNN | 61 | Q2PPJ7 | |
| QARQALDKLNGFQLE | 131 | O00425 | |
| LDKLNGFQLENFTLK | 136 | O00425 | |
| DALNKNQFLKRLDPQ | 161 | Q13237 | |
| ELDQTGNQLKFLSQK | 6501 | Q9UPN3 | |
| GNQLKFLSQKQDVVL | 6506 | Q9UPN3 | |
| SGNLVAQKADILNKN | 81 | A6NG13 | |
| QKLQELKAILRGFNA | 411 | O60244 | |
| GLQDSAQLGNLLKFN | 261 | O75864 | |
| GNQNKLIQELKTAKA | 1071 | Q15075 | |
| LLQKFQKDLNTGVFN | 601 | O60741 | |
| NGTLKEINASLNQEK | 976 | P49454 | |
| EKAQLLQGLDEAKNN | 2481 | P49454 | |
| LLTQQQKGQLFSEKL | 671 | Q9H799 | |
| NFELVSELKKLNGAN | 236 | Q9P109 | |
| GQFENKTNLKNQLIL | 471 | P54289 | |
| RALAFNNKNKELGAV | 256 | Q5T6F0 | |
| VENQLSGNLLRKFKN | 931 | Q9Y4F1 | |
| LKVAQGKALQENLAL | 1411 | Q9BV73 | |
| NGKLDLAADKIEQFN | 726 | Q8WXX0 | |
| SGIDFKQLNFLTKLN | 186 | Q13418 | |
| QQQLAFLEGRKKQLL | 491 | Q6P1N0 | |
| IQLSNQELLGDDQKK | 2781 | Q5VT06 | |
| NEINKLLSEQDGSLK | 246 | P08034 | |
| FLKDQNIFVQKLLGQ | 251 | P53004 | |
| NKNEVNDKFSIGDLQ | 111 | Q9NS73 | |
| QNLDALLNQLKSFPA | 1361 | Q14204 | |
| ALENLNLKESNKGNE | 361 | Q9P0J7 | |
| DLNKLNEIEGTLNKA | 1531 | P11047 | |
| YLNVLEQKQKALNAG | 531 | Q9Y678 | |
| LLQDFFNGKELNKSI | 351 | P17066 | |
| LEAFNSNGNNLQLKD | 291 | Q86UP6 | |
| NNKEKNSILFLNSLD | 321 | Q8IXB1 | |
| ENKILNSELENGKQN | 891 | A2RUR9 | |
| LEKIQKFNLLLENSG | 566 | Q96MH7 | |
| QGELEAFIQNLNLAK | 81 | Q03701 | |
| VIQQGAFLGLNKLKQ | 111 | Q9H756 | |
| LENLIKTLKNAAEGN | 286 | Q8WV60 | |
| IQKLLQDFFNGKELN | 346 | P11142 | |
| NKQSNAFKALLQEFD | 516 | Q02241 | |
| GFANLDLNDQVTLLK | 296 | Q07869 | |
| NKNLFDNLIEFLQKS | 66 | Q9UBD5 | |
| NFLGLEEEGNLKKFQ | 2011 | P56715 | |
| NLDLTGQKQVFKAEN | 201 | Q15404 | |
| LGDQDKAKQIQDQLN | 526 | Q92541 | |
| VKNGEKDIQTALNNA | 306 | O95397 | |
| FAINIDNKDLNGQSK | 21 | Q8IUI4 | |
| FQNQKGAIENLLAKL | 316 | Q9UPN9 | |
| NQNEKIDGKAGLFLL | 366 | P0CI25 | |
| ILFAINIDNKDLNGQ | 171 | Q8TEQ0 | |
| ISLKKEFLNLQDENQ | 481 | Q8WXA3 | |
| NNNLFLSLGLQEKIL | 116 | Q7Z6W1 | |
| AAVQKFLEQNGQLGK | 5481 | Q8NF91 | |
| LEFDQLQLQKSSGKI | 751 | O15056 | |
| PQLAENKQQFGNLKE | 26 | P0DPF3 | |
| LGLFIKSKQQLSDNQ | 1281 | Q9P212 | |
| FDKLKLTNNELDDQG | 216 | Q96SF7 | |
| DNFNQQKKKLGGQDI | 1471 | Q14524 | |
| QDRNNFFLSLKKLDG | 226 | O43173 | |
| KNQFESLKQLQSLDL | 346 | Q8WXD0 | |
| FENTFLRLKLNNLNK | 91 | Q562F6 | |
| ALKQKLAQAQDALDA | 351 | Q9UIF3 | |
| TKENLVFLAQKLFNN | 526 | P51692 | |
| KVLQDNLDKLQALAN | 716 | Q9UQ90 | |
| ALLENLKLRKQNNGA | 711 | P02786 | |
| LKLRKQNNGAFNETL | 716 | P02786 | |
| DQLQAQDFSKFQPLK | 361 | Q9NZN3 | |
| TKENLVFLAQKLFNN | 526 | P42229 | |
| NLVNFILNAKDGIKA | 191 | P59095 | |
| RSQGQQQEKKQFDLL | 186 | P52594 | |
| QLENGFKQLENSKRK | 126 | Q15642 | |
| EQLKFNLQLKADLSD | 231 | Q7RTR0 | |
| DGSFLQQFLKLQKAQ | 86 | Q8IWZ8 | |
| GEAFSQILNLNLNKK | 81 | Q8TBZ8 | |
| LDLQNLIDFGQKKFS | 141 | Q86UF1 | |
| DQGFLELENQFKKTQ | 981 | Q9Y4E5 | |
| DRVFQKLGNLKQQAE | 186 | O95229 | |
| DLQNIENALKGKANI | 146 | Q9P2K2 | |
| DISNGFKNLNLNAAL | 571 | Q9Y5T5 | |
| NLAKFNQVLDQFGEK | 371 | O43242 | |
| NLQNAFNLAEKELGL | 236 | O15020 | |
| SENNKKLFNDLFKNN | 751 | Q9Y5W7 | |
| LKQRNGALDQQKDEL | 1581 | P12270 | |
| PENQNFLLESNLGKK | 46 | Q96QD8 | |
| LELLKKESQNLENNF | 106 | Q8TAQ9 | |
| DLDFAQQKLTDKNLG | 1001 | Q8IX01 | |
| NGSSQANKLIKEELQ | 161 | P29144 | |
| ANVGLNLKFNKKNEE | 951 | Q8IZH2 | |
| NEAKEKAALFALQQL | 1491 | Q8IZH2 | |
| QTLAQKDQALGKLEQ | 241 | Q13077 | |
| LGEKEAKLAQQSQAL | 211 | P19474 | |
| ALEEAQKAIQQLFGK | 96 | Q5VIR6 | |
| QKKFDLQLAQALGES | 1606 | Q8IUG5 | |
| NNFQKQLLSNKELIL | 51 | Q53FD0 | |
| NNSKDFGQLALELLD | 671 | Q7Z4N2 | |
| DFLKVFQGKNSQLQE | 121 | Q9UJU3 | |
| GDDLQSKTNKFILNQ | 311 | P59923 | |
| KNGDIKNAQEALQAI | 311 | O43592 | |
| KEQNNLKQLEFGLKE | 151 | P17098 | |
| LLKQASGKNLNLNDE | 196 | Q9UIA9 | |
| AAAAKLAQQELQKAQ | 911 | Q9UPP1 | |
| GKTEELQQQLNLEKF | 491 | P0C1S8 | |
| NNIDGKELLNLTKES | 356 | Q8N9V3 | |
| LGINSLQELKQNIAK | 111 | P55327 | |
| LSKLGNFNLQDIEKD | 491 | Q5VYS8 | |
| LETNEGLKKFLQNFL | 171 | Q9NVH6 | |
| LDKLSANQQNILKFI | 146 | P57088 | |
| DLIQQLSEKFGKNLN | 836 | Q9HCX4 | |
| AALSQLLEGLNNKKN | 2126 | Q9P2D8 | |
| EKNLKLQLSTLNNAG | 791 | Q96L42 | |
| LANNNLQTLPKDIFK | 146 | O95970 |